Nicolas Villain

Sorbonne Université

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Scott Ayton

University of Melbourne

AUSTRALIA

View details

Leonie N. C. Visser

NETHERLANDS

View details

Ruth Stephen

Karolinska Institutet

SWEDEN

View details

Howard Feldman

Professor

University of California, San Diego

UNITED STATES

View details

Andre Strydom

King’s College London

UNITED KINGDOM

View details

Vincent Planche

University of Bordeaux

FRANCE

View details

Alessandra Dodich

University of Trento

ITALY

View details

Junyue Ge

University of Gothenburg

SWEDEN

View details

Rahul Gaurav

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nicolas Villain

Research Interests

Explore related searches

Contact this professor

Articles (18)

Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics

Early brain iron changes in Parkinson's disease and isolated rapid eye movement sleep behaviour disorder: a four-year longitudinal multimodal quantitative MRI study

An International Working Group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer’s disease

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Disentangling clinical and biological trajectories of neurodegenerative diseases

What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

2024 AA criteria for Alzheimer's disease diagnosis: Mainly anchored at Aβ not tau

Clinical versus biomarker-based diagnosis of neurocognitive disorders - Authors' reply.

The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test.

Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease

Dementia prevention in memory clinics: recommendations from the European task force for brain health services

Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease

Dementia prevention in memory clinics: recommendations from the European task force for brain health services

A Comparison Between Early Presentation of Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease: Evidence from Routine Primary Care and UK Biobank Data

Advocating for Demonstration of Disease Modification-Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?

Can a failure in the error-monitoring system explain unawareness of memory deficits in Alzheimer's disease?

Validation study of "Sante-Cerveau", a digital tool for early cognitive changes identification

Collaborators (9)

Scott Ayton

Leonie N. C. Visser

Ruth Stephen

Howard Feldman

Andre Strydom

Vincent Planche

Alessandra Dodich

Junyue Ge

Rahul Gaurav

Make your next move.